SPONSOR
Jiangsu Renocell Biotech Company
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Systemic Sclerosis
Jiangsu Renocell Biotech Company is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Systemic Sclerosis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jiangsu Renocell Biotech Company
How many clinical trials has Jiangsu Renocell Biotech Company sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Jiangsu Renocell Biotech Company, of which 1 are actively recruiting participants. These trials cover conditions including Systemic Sclerosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jiangsu Renocell Biotech Company research focus on?
Jiangsu Renocell Biotech Company clinical trials span Systemic Sclerosis. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jiangsu Renocell Biotech Company clinical trial?
To participate in a Jiangsu Renocell Biotech Company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jiangsu Renocell Biotech Company trials with current recruitment status updated daily.
Clinical Trials by Jiangsu Renocell Biotech Company
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology